Paul E. Goss - Concepedia

Author

Paul E. Goss

Toronto General Hospital

Also Known As

Goss, Paul E, P E Goss, P Goss, P. E. Goss, P. Goss, P.E. Goss, Paul E Goss, Paul E. Goss, Paul Edward Goss, Paul Goss

110

Publications

15.6K

Citations

H-Index

Concepts

All Affiliations

Toronto General Hospital University of Toronto Massachusetts General Hospital Princess Margaret Cancer Centre Queen's University

About

Paul E. Goss is an author at Toronto General Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	33	5.8K
2	Health Sciences	7	7	3.9K
3	Biochemistry	2	2	62
4	Natural Sciences	1	1	33
5	Nursing	1	1	3.6K

Paul E. Goss

Publications

9.9K

Citations

H-Index

Page 1

	Year	Citations
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Annals of Oncology Surgical OncologyBreast OncologyCancer ManagementPrimary TherapyPathology	2013	3.6K
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer Steven J. Isakoff, Erica L. Mayer, Lei He, Journal of Clinical Oncology	2015	412
Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer Elizabeth Warner, William D. Foulkes, Pamela J. Goodwin, JNCI Journal of the National Cancer Institute	1999	391
Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials Scott D. Solomon, Janet Wittes, Peter Finn, Circulation	2008	354
A Five-Gene Molecular Grade Index and <i>HOXB13:IL17BR</i> Are Complementary Prognostic Factors in Early Stage Breast Cancer Xiaojun Ma, Ranelle Salunga, Sonika Dahiya, Clinical Cancer Research	2008	308
Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17 Edith A. Perez, Robert G. Josse, Kathleen I. Pritchard, Journal of Clinical Oncology	2006	303
Do genetic factors explain associations between muscle strength, lean mass, and bone density? A twin study Ego Seeman, John L. Hopper, N Young, American Journal of Physiology-Endocrinology and Metabolism	1996	261
Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, Journal of Clinical Oncology	2013	258
Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women Timothy J. Whelan, Paul E. Goss, James N. Ingle, Journal of Clinical Oncology	2005	241
Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Mitch Dowsett, Paul E. Goss, TJ Powles, PubMed Breast OncologyGynecologyPharmacotherapyPostmenopausal Breast CancerAnti-cancer Agent	1987	240

Page 1